Launch week offerEnds in00h00m00s

annual Promonthly Pro

DINA VISCA

Italy

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Italy Professors in Epidemiology Epidemiology professors in Italy

Articles (12)

Year:

2025

Year:

2025

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

Gianenrico Senna

Head

University of Verona

ITALY

View details

Giuseppe Guida

Associate Professor of Respiratory Medicine

Università degli Studi di Torino

ITALY

View details

Laura Pini

Prof

University of Brescia

ITALY

View details

Frank Rikki CANEVARI

Professore Associato

Università degli Studi di Torino

ITALY

View details

Marco Caminati

University of Verona

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

DINA VISCA

Research Interests

Make your next move.

Explore related searches

Articles (12)

Dupilumab Effectiveness in Patients with Severe Allergic Asthma Non-Responsive to Omalizumab

Cytokine and Metabolomic Signatures of Mepolizumab Response Across Upper and Lower Airway Compartments in Severe Eosinophilic Asthma: An Exploratory Analysis

Mepolizumab Improves Outcomes of Chronic Rhinosinusitis with Nasal Polyps in Severe Asthmatic Patients: A Multicentric Real-Life Study

TB and COVID-19 co-infection: rationale and aims of a global study

A snapshot of exhaled nitric oxide and asthma characteristics: experience from high to low income countries

Active tuberculosis, sequelae and COVID-19 co-infection: First cohort of 49 cases

Chronic cough in adults

Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)

Correction to: When kidneys and lungs suffer together (Journal of Nephrology, (2019), 32, 5, (699-707), 10.1007/s40620-018-00563-1)

Cost-effectiveness of ambulatory oxygen in improving quality of life in fibrotic lung disease: Preliminary evidence from the AmbOx Trial

Current developments and future directions in COPD

Defining genetic risk factors for scleroderma-associated interstitial lung disease: IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease

Collaborators (5)

Gianenrico Senna

Giuseppe Guida

Laura Pini

Frank Rikki CANEVARI

Marco Caminati

Make your next move.